At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:27 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,535,192.79 shares of Twist Bioscience Corp common stock, representing 14.4% of shares outstanding as of September 30, 2026. This is a routine passive stake update; the prior filing (September 8, 2026) did not disclose a specific share count or percentage in the provided context, so the direction of change cannot be determined from the documents alone.
- FMR LLC reported beneficial ownership of 9,535,192.79 shares of Twist Bioscience Corp common stock as of September 30, 2026.
- The stake represents 14.4% of total outstanding common stock.
- Fidelity Global Innovators Investment Trust held 3,476,508 shares (5.2%) of the total outstanding common stock as of September 30, 2026.
- The filing is a passive Schedule 13G/A amendment under Rule 13d-1(b).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access